Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

about

Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.

P2860

Q30370543-0FA2F9C9-D10E-4F9D-9700-8A99E2C905E4

P2860

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

Item

http://www.wikidata.org/entity/Q42371164

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@en

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@nl

type

Item

label

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@en

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@nl

prefLabel

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@en

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@nl

P1476

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

@en

P2093

Anna Gooch

http://www.w3.org/2001/XMLSchema#string

Christof Westenfelder

http://www.w3.org/2001/XMLSchema#string

P2860

Adult Mesenchymal Stem Cells: When, Where, and How

Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.

The growth hormone-insulin-like growth factor axis in kidney re-revisited.

Mesenchymal stem cells in acute kidney injury.

Kidney protection and regeneration following acute injury: progress through stem cell therapy.

Insulin-like growth factors and kidney disease.

A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion.

Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy.

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.

IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.

P304

2219-2221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1681/ASN.2015121379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26869007

http://www.w3.org/2001/XMLSchema#string

P921

hydrogel

P932

4978064

http://www.w3.org/2001/XMLSchema#string

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

about

P2860

P2860

Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932